NGEN:CA Stock

In a Nov. 24 update, Research Capital analyst André Uddin maintained his “Speculative Buy” rati... Read More

Research Capital analyst Andre Uddin lowered his target price for NervGen Pharma (NervGen Pharma Sto... Read More

NervGen Pharma (NervGen Pharma Stock Quote, Chart, News, Analysts, Financials TSXV:NGEN) has appoint... Read More

Paradigm Capital has doubled its price target on NervGen Pharma (NervGen Pharma Stock Quote, Chart, ... Read More

Raymond James analyst Michael W. Freeman thinks NervGen Pharma (NervGen Pharma Corp Stock Quote, Cha... Read More